Evidence map›Paper›PMID 34907809›Full record

ArticleScience progress2021

Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients.

Hang Fang, Min Zhang, Chongshun Zhao, Xia Yao, Haizhen Wang, Hailing Xia, Min Yu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science progress, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Hang FangDepartment of Clinical Laboratory, The First People's Hospital of YongKang, Yongkang, Zhejiang, China.
Min ZhangSchool of Public Heath, 117839Hangzhou Medical College, Hangzhou, Zhejiang, China.
Chongshun ZhaoDepartment of Health & Medical Information, The First People's Hospital of YongKang, Yongkang, Zhejiang, China.
Xia YaoDepartment of Clinical Laboratory, The First People's Hospital of YongKang, Yongkang, Zhejiang, China.
Haizhen WangDepartment of Respiratory Medicine, The First People's Hospital of YongKang, Yongkang, Zhejiang, China.
Hailing XiaSchool of Public Heath, 117839Hangzhou Medical College, Hangzhou, Zhejiang, China.
Min YuSchool of Public Heath, 117839Hangzhou Medical College, Hangzhou, Zhejiang, China.ORCID 0000-0002-5909-1475
Hangzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) increases the global disease burden due to its diverse adverse health effects on the respiratory and cardiovascular systems. This study aimed to elucidate the potential indicators of length of stay (LOS) and pharmacotherapy advice among COPD patients. Thereafter, hospitalized COPD patients with clinical records and respiratory and cardiovascular pharmacotherapy advice were retrospectively collected from a tertiary hospital between April 2017 and September 2020, and the determinants of LOS and cardiovascular pharmacotherapy advice were explored using regression analyses. Overall, 475 patients with COPD were recruited and stratified according to exacerbation and presence of Cor pulmonale (CP). The extended LOS, increased B-type natriuretic peptides (BNP), and a higher percentage of cardiovascular pharmacotherapy advice were observed in COPD with CP regardless of exacerbation, although the percentage of respiratory prescriptions was comparable. The presence of CP indicated a longer LOS (

Indexed as

Cardiovascular SystemHypertension, PulmonaryPulmonary Disease, Chronic ObstructivePulmonary Heart DiseaseHumansLength of StayRetrospective Studiesb-type natriuretic peptideschronic obstructive pulmonary diseasecor pulmonalehospitalizationpharmacotherapy advice

Identifiers

PMID34907809
PMCPMC10450607
OpenAlexW4200099654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.